• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Clifton Leaf

Clifton "Cliff" Leaf is a former editor-in-chief of Fortune.

    Page 39 of 47

  • Health

    Trump Proves Biopharma’s Drug Pricing Complacency Is a Huge Mistake

    By Sy Mukherjee and Clifton Leaf
  • Obama Speaks At National Prayer BreakfastHealth

    MIA in the Medical Revolution: A Sense of Urgency

    By Clifton Leaf
  • Health

    MIA in the Medical Revolution: A Sense of Urgency

    By Sy Mukherjee and Clifton Leaf
  • The Golden Gate Bridge, San Francisco, CaliforniaHealth

    Biopharma’s Burning Man

    By Clifton Leaf
  • Health

    Biopharma’s Burning Man

    By Sy Mukherjee and Clifton Leaf
  • Hormel Foods To Buy Skippy Peanut Butter From Unilever For $700mHealth

    Finally, A New Approach on Peanut Allergies

    By Clifton Leaf
  • Health

    Finally, A New Approach on Peanut Allergies

    By Sy Mukherjee and Clifton Leaf
  • South Korean Economy Boosted As Won Jumps To New HighHealth

    The Investments We’re Making—And Not Making—In Digital Health

    By Clifton Leaf
  • Health

    The Investments We’re Making—And Not Making—In Digital Health

    By Sy Mukherjee and Clifton Leaf
  • Health

    My Crystal Ball Reading for Obamacare

    By Sy Mukherjee and Clifton Leaf
  • A Tea-Party supporter protest outside thHealth

    My Crystal Ball Reading for Obamacare

    By Clifton Leaf
  • Pharmaceutical Production Inside Merck KGaA Health Care LaboratoryHealth

    The Perils of Polypharmacy

    By Clifton Leaf
  • Health

    The Perils of Polypharmacy

    By Sy Mukherjee and Clifton Leaf
  • A VISIONARY: HEALTH CARE FOR EVERYONE, EVERYWHEREHealth

    Three Things I Learned This Year About the Healthcare Revolution

    By Clifton Leaf
  • Health

    Three Things I Learned This Year About the Healthcare Revolution

    By Sy Mukherjee and Clifton Leaf
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.